Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear CBS members, Greetings The Montreal Student Chapter of the Canadian Biomaterials Society is thrilled to invite you to a CBS Lunchtime webinar series talk and a lab tour on April 10th This event will feature an online presentation by Professor Darcy Wagner from McGill University at noon and an in-person lab tour starting at 4 30pm meet at RI-MUHC, Bloc E Atrium ...

Dear CBS Members, This is a friendly reminder that the abstract deadline for CBS2025 is today Submit your abstracts here...

Calling all ECR Faculty Members for Keynote Presentation Opportunities Dear CBS Members, A feature of CBS2025 will be presentations from current Early Career Researcher ECR faculty member highlighting their expertise and new research...

CBS2025 abstract submission deadline is extended until February 7th We know it is a busy time of year and so we are happy to announce that the CBS 2025 abstract submission deadline for the 39th Annual Meeting of the Canadian Biomaterial Society has been extended until February 7th, 2025 please note that this will be the last extension The CBS2025 Organizing Committee invites you to submit your abstracts related to biomaterials research through the Oxford Abstracts submission portal...

The natural tumor microenvironment TME features dynamic mechanical and biological variations that affect cell physiology and function 1 ...

Wet age-related macular degeneration AMD is a disease of the posterior chamber of the eye and is the leading cause of vision loss in those 50 years of age and older, with approximately 500,000 people worldwide losing their vision annually...

Contact lens surfaces may be ionic or electrically neutral. Base on how different lenses interact with various lens care solutions and how they are affected by interaction of different proteins or lipids from tear film, FDA categorised soft contact lenses into 4 distinct groups including two ionic contact lens Group III and group IV...

Arterial bypass graft is the primary therapy for patients with advanced vascular occlusion diseases and, in recent years, the development of tissue-engineered vascular grafts has emerged as a promising, clinically applicable alternative to autografts...

Biomaterials designed for bone tissue engineering must be biocompatible and biodegradable and must promote bone cell attachment, proliferation, and migration such that the damaged tissue is repaired or replaced with the newly regenerated bone over time...